We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Will Trading Volume Aid CME Group to Deliver Q1 Earnings Beat?
Read MoreHide Full Article
CME Group (CME - Free Report) is expected to register an improvement in its top line and bottom line when it reports first-quarter 2025 results on April 23, before the opening bell.
The Zacks Consensus Estimate for CME’s first-quarter revenues is pegged at $1.6 billion, indicating 9.6% growth from the year-ago reported figure.
The consensus estimate for earnings is pegged at $2.76 per share. The Zacks Consensus Estimate for CME’s first-quarter earnings has moved up 5.7% in the past 30 days. The estimate suggests a year-over-year increase of 10.4%. (Find the latest EPS estimates and surprises on Zacks Earnings Calendar.)
What the Zacks Model Unveils for CME
Our proven model predicts an earnings beat for CME this time around. This is because it has the right combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy), or 3 (Hold) that increases the chances of an earnings beat.
You can uncover the best stocks to buy or sell before they are reported with our Earnings ESP Filter.
Earnings ESP: CME has an Earnings ESP of +1.82%. This is because the Most Accurate Estimate of $2.81 is pegged higher than the Zacks Consensus Estimate of $2.76.
CME Group’s first-quarter performance is likely to have benefited from a diverse product portfolio, increased volatility and a strong market position.
Revenues are likely to have benefited from an increase in market data and information services, clearing, transaction fees and other revenues.
Higher trading volumes across asset classes are likely to have driven clearing and transaction fees. We expect clearing and transaction fees to be $1.2 billion, indicating a 2.9% increase from the year-ago reported figure. The Zacks Consensus Estimate for first-quarter clearing and transaction fees is pegged at $1.3 billion, indicating a rise of 28.8% from the year-ago reported figure.
CME reported a record quarterly average daily volume of 29.8 million contracts in the first quarter, up 13% year over year. This was driven by record quarterly growth in various asset classes, with record volume in Interest Rate, Equity Index, Agricultural, Foreign Exchange and Cryptocurrency products. International ADV reached a record 8.8 million contracts, up 19% year on year.
Market data and information services revenues are likely to have gained from price increases for certain products, a rise in device counts, higher custody fees as well as improvements in co-location and other connectivity fees. We expect the figure to be $188.6 million, indicating a 7.5% increase from the year-ago reported figure. The Zacks Consensus Estimate for first-quarter market data and information services revenues is pegged at $187 million, indicating an increase of 6.9% from the year-ago reported figure.
Expenses are likely to have increased in the to-be-reported quarter due to higher compensation and benefits and technology expenses. We anticipate expenses to be $492 million in the to-be-reported quarter, indicating a 6.5% increase from the year-ago reported figure.
Other Stocks to Consider
Here are three finance stocks you may want to consider, as our model shows that these also have the right combination of elements to post an earnings beat:
Nasdaq (NDAQ - Free Report) has an Earnings ESP of +1.32% and a Zacks Rank #3 at present. The Zacks Consensus Estimate for first-quarter 2025 earnings is pegged at 77 cents, indicating a year-over-year decrease of 22.2%
NDAQ’s earnings beat estimates in three of the last four reported quarters and missed in one.
Intercontinental Exchange (ICE - Free Report) has an Earnings ESP of +0.88% and a Zacks Rank #2 at present. The Zacks Consensus Estimate for first-quarter 2025 earnings is pegged at $1.70, indicating a year-over-year decrease of 14.9%.
ICE’s earnings beat estimates in two of the last four reported quarters while meeting the same in the other two.
Cboe Global Markets (CBOE - Free Report) has an Earnings ESP of +3.62% and currently carries a Zacks Rank of 2. The Zacks Consensus Estimate for first-quarter 2025 bottom line is pegged at $2.29, implying an increase of 6.5% from the year-ago reported figure.
CBOE’s earnings beat estimates in three of the last four reported quarters and missed in one.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Will Trading Volume Aid CME Group to Deliver Q1 Earnings Beat?
CME Group (CME - Free Report) is expected to register an improvement in its top line and bottom line when it reports first-quarter 2025 results on April 23, before the opening bell.
The Zacks Consensus Estimate for CME’s first-quarter revenues is pegged at $1.6 billion, indicating 9.6% growth from the year-ago reported figure.
The consensus estimate for earnings is pegged at $2.76 per share. The Zacks Consensus Estimate for CME’s first-quarter earnings has moved up 5.7% in the past 30 days. The estimate suggests a year-over-year increase of 10.4%. (Find the latest EPS estimates and surprises on Zacks Earnings Calendar.)
What the Zacks Model Unveils for CME
Our proven model predicts an earnings beat for CME this time around. This is because it has the right combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy), or 3 (Hold) that increases the chances of an earnings beat.
You can uncover the best stocks to buy or sell before they are reported with our Earnings ESP Filter.
Earnings ESP: CME has an Earnings ESP of +1.82%. This is because the Most Accurate Estimate of $2.81 is pegged higher than the Zacks Consensus Estimate of $2.76.
CME Group Inc. Price and EPS Surprise
CME Group Inc. price-eps-surprise | CME Group Inc. Quote
Zacks Rank: CME sports a Zacks Rank #1. You can see the complete list of today’s Zacks #1 Rank stocks here.
Factors Likely to Shape Q1 Results
CME Group’s first-quarter performance is likely to have benefited from a diverse product portfolio, increased volatility and a strong market position.
Revenues are likely to have benefited from an increase in market data and information services, clearing, transaction fees and other revenues.
Higher trading volumes across asset classes are likely to have driven clearing and transaction fees. We expect clearing and transaction fees to be $1.2 billion, indicating a 2.9% increase from the year-ago reported figure. The Zacks Consensus Estimate for first-quarter clearing and transaction fees is pegged at $1.3 billion, indicating a rise of 28.8% from the year-ago reported figure.
CME reported a record quarterly average daily volume of 29.8 million contracts in the first quarter, up 13% year over year. This was driven by record quarterly growth in various asset classes, with record volume in Interest Rate, Equity Index, Agricultural, Foreign Exchange and Cryptocurrency products. International ADV reached a record 8.8 million contracts, up 19% year on year.
Market data and information services revenues are likely to have gained from price increases for certain products, a rise in device counts, higher custody fees as well as improvements in co-location and other connectivity fees. We expect the figure to be $188.6 million, indicating a 7.5% increase from the year-ago reported figure. The Zacks Consensus Estimate for first-quarter market data and information services revenues is pegged at $187 million, indicating an increase of 6.9% from the year-ago reported figure.
Expenses are likely to have increased in the to-be-reported quarter due to higher compensation and benefits and technology expenses. We anticipate expenses to be $492 million in the to-be-reported quarter, indicating a 6.5% increase from the year-ago reported figure.
Other Stocks to Consider
Here are three finance stocks you may want to consider, as our model shows that these also have the right combination of elements to post an earnings beat:
Nasdaq (NDAQ - Free Report) has an Earnings ESP of +1.32% and a Zacks Rank #3 at present. The Zacks Consensus Estimate for first-quarter 2025 earnings is pegged at 77 cents, indicating a year-over-year decrease of 22.2%
NDAQ’s earnings beat estimates in three of the last four reported quarters and missed in one.
Intercontinental Exchange (ICE - Free Report) has an Earnings ESP of +0.88% and a Zacks Rank #2 at present. The Zacks Consensus Estimate for first-quarter 2025 earnings is pegged at $1.70, indicating a year-over-year decrease of 14.9%.
ICE’s earnings beat estimates in two of the last four reported quarters while meeting the same in the other two.
Cboe Global Markets (CBOE - Free Report) has an Earnings ESP of +3.62% and currently carries a Zacks Rank of 2. The Zacks Consensus Estimate for first-quarter 2025 bottom line is pegged at $2.29, implying an increase of 6.5% from the year-ago reported figure.
CBOE’s earnings beat estimates in three of the last four reported quarters and missed in one.